Neuropsychiatric effects of tamoxifen: Challenges and opportunities
2020 · Frontiers in Neuroendocrinology · 50 citations
https://doi.org/10.1016/j.yfrne.2020.100869
C
Christopher D. Schneck
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
71
Papers
3.1K
Citations
25
h-index
36
i10-index
Christopher D. Schneck is an academic researcher from University of Colorado Anschutz Medical Campus. The author has contributed to research in topics: Bipolar Disorder and Treatment & Child and Adolescent Psychosocial and Emotional Development & Adolescent and Pediatric Healthcare. The author has an h-index of 25, co-authored 61 publications.
ORCID: 0000-0002-7422-4707Papers by this author
worksClinical decision support for bipolar depression using large language models
2024 · Neuropsychopharmacology · 50 citations
https://doi.org/10.1038/s41386-024-01841-2
Effects of family-focused therapy on suicidal ideation and behavior in youth at high risk for bipolar disorder
2020 · Journal of Affective Disorders · 32 citations
https://doi.org/10.1016/j.jad.2020.06.015
A Pharmacologic Algorithm for Youth Who Are at High Risk for Bipolar Disorder
2017 · Journal of Child and Adolescent Psychopharmacology · 28 citations
https://doi.org/10.1089/cap.2017.0035
Early intervention for youth at high risk for bipolar disorder: A multisite randomized trial of family‐focused treatment
2017 · Early Intervention in Psychiatry · 28 citations
https://doi.org/10.1111/eip.12463
National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder
2023 · Journal of Affective Disorders · 6 citations
https://doi.org/10.1016/j.jad.2023.11.008
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat